ADI vs ERNA · P/E 61, rev $11.02B vs P/E 0.0, rev $582.0K
Analog Devices Inc (ADI) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the ADI and ERNA stock pages for the full models.
Not investment advice.